Depression: The Toughest
Part of Bipolar Disorder
(June 20 2002) -- It's one of the
most missed diagnoses in psychiatry. Bipolar disorder, involving moods that
swing between the highs of mania and the lows of
depression, is typically
confused with everything from unipolar depression to
schizophrenia to
substance
abuse, to
borderline personality disorder, with just about all stops in between.
Patients themselves often resist diagnosis, because they may not see as
pathologic the surge in energy that accompanies the
mania or
hypomania that
distinguishes the condition.
But on a few points consensus is
emerging. Bipolar disorder is a chronically recurring illness. And the age of
onset is dropping--in less than one generation it has gone from age 32 to 19.
Whether there is a genuine increase in prevalence of the disorder is a matter of
some debate, but there does seem to be a genuine increase among the young.
What's more, the depression of
manic-depression is emerging as a particularly thorny problem for both patients
and their doctors.
"Depression is the bane of treatment
of bipolar disorder," says Robert M.A. Hirschfeld, M.D., head of psychiatry at
the University of Texas Medical Branch in Galveston.
It's what is most likely to motivate
patients to accept care. People spend more time in the depression phase of the
disorder. And unlike unipolar depression, the depression of bipolar illness
tends to be treatment-resistant.
"Antidepressants don't work very
well in bipolar depression," says Dr. Hirschfeld. "They are underwhelming in
their ability to treat the depression." In fact, a shift away from
antidepressants is formally recognized in new treatment guidelines for bipolar
disorder just released by the American Psychiatric Association.
As physicians gain experience in
treating the disorder, they are discovering that
antidepressants have two
negative effects on the course of the disorder. Used by themselves,
antidepressants can induce manic episodes. And over time they can accelerate
mood cycling, increasing the frequency of episodes of depression or of mania
followed by depression.
Instead, research points to the
value of drugs that work as
mood stabilizers for the depression of bipolar
disorder, either alone or in combination with antidepressants. If
antidepressants have any use at all in bipolar disorder, it may be as acute
treatment for bouts of severe depression before mood stabilizers are added or
substituted.
Even in cases of severe depression,
the new guidelines favor increasing the dosage of mood stabilizers over other
strategies.
Until recently, mood stabilizers
could be summed up in a single word--lithium, in use since the 1960s to tame
mania. But over the past decade research has additionally demonstrated the
effectiveness of divalproex sodium (Depakote) and lamotrigine (Lamictal), drugs
that were initially developed for use as anticonvulsants in seizure disorders.
Divalproex sodium has been approved for use as a mood stabilizer in bipolar
disorder for several years, while lamotrigine is currently undergoing clinical
trials for such an application.
"Optimizing the dose of lithium or
divalproex has good antidepressant effects," reports Dr. Hirschfeld. "We also
now know that divalproex and lamotrigine are very good for preventing recurrence
in bipolar patients." A recent study showed that lamotrigine not only delays the
time to any mood events but is notably effective against the depressive lows of
bipolar illness.
No one knows for sure exactly how
anticonvulsants work in bipolar disorder. For that matter, the condition has
been described since the time of Hippocrates, but it is still not clear what
goes awry in manic-depression.
Despite the unknowns, medications
for treating the disorder are proliferating. In contrast to downplaying
antidepressants in the depressive phase of the disorder, clinical research is
ramping up the value of antipsychotic drugs for combating the manic phase,
albeit a new generation of such drugs, collectively called atypical
antipsychotics. Chief among them are olanzapine (Zyprexa) and risperidone (Risperdal).
They are now considered a first-line approach to acute mania, and adjuncts for
long-term therapy along with mood stabilizers.
In the long term, however, observes
Nassir Ghaemi, M.D., assistant professor of psychiatry at Harvard and head of
bipolar research at Cambridge Hospital, medication goes only so far. "Drugs are
not effective enough. It may have to do with the overuse of antidepressants;
they interfere with the benefits of mood stabilizers.
"Medications don't take you to the
finish line." There seem to be residual symptoms of depression that don't clear.
Even when patients stabilize into a normal, or euthymic, mood state, he says,
some troubling signs can appear.
"Sometimes we see in euthymic
patients cognitive dysfunction that we didn't expect in the past--word-finding
difficulties, trouble maintaining concentration," Dr. Ghaemi explains.
"Cumulative cognitive impairment seems to emerge with time. It may be related to
findings of decreased size of the hippocampus, a brain structure that serves
memory. We are on the verge of recognizing long-term cognitive impairment as a
result of bipolar disorder."
He believes there is a role for
aggressive psychotherapy for keeping patients well, for keeping everyday ups and
downs from becoming full-blown episodes. At the very least, he finds,
psychotherapy can help patients resolve the work and relationship problems that
often outlast symptoms.
In addition, psychotherapy can help
patients learn new coping styles and interpersonal habits. "Many of
the ways
patients deal with their illness are not relevant when they are well," explains
Dr. Ghaemi.
For example, he says, many people
develop the habit of staying up late as a way of coping with the manic symptoms.
"What they couldn't change before because of the illness needs to be changed
after treatment if, for example, it bothers a spouse. People have to learn to
change. But the longer one is ill, the harder it is to become completely well,
because the harder it is to change the habits of one's life."
And for young people diagnosed with
bipolar illness, he considers psychotherapy essential. "The younger patients
are, the less convinced they are that they have bipolar disorder," he says.
"They have impaired insight. They're especially concerned about the need to take
medications. They should be in psychotherapy to get educated about the illness
and medication."
He also stresses the value of
support groups, especially for young people. "It's another, important layer of
validation."
top ~
next ~
send page to a
friend
|